Author
Listed:
- Chun-Gu Cheng
(Department of Emergency, Taoyuan Armed Forces General Hospital, Taoyuan 32549, National Defense Medical Center, Taipei 11490, Taiwan
Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan
Department of Emergency and Critical Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan)
- Hsin Chu
(Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan
Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei 11490, Taiwan)
- Jiunn-Tay Lee
(Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan)
- Wu-Chien Chien
(Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan
School of Public Health, National Defense Medical Center, Taipei 11490, Taiwan
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 11490, Taiwan)
- Chun-An Cheng
(Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan)
Abstract
(1) Background: Patients with benign prostatic hyperplasia (BPH) were questioned about quality of life and sleep. Most BPH patients were treated with alpha-1 adrenergic receptor antagonists, which could improve cerebral blood flow for 1–2 months. Patients with ischemic stroke (IS) could experience cerebral autoregulation impairment for six months. The relationship between BPH and recurrent IS remains unclear. The aim of this study was to determine the risk of one-year recurrent IS conferred by BPH. (2) Methods: We used data from the Taiwanese National Health Insurance Database to identify newly diagnosed IS cases entered from 1 January 2008 to 31 December 2008. Patients were followed until the recurrent IS event or 365 days after the first hospitalization. The risk factors associated with one-year recurrent IS were assessed using Cox proportional hazards regression. (3) Results: Patients with BPH had a higher risk of recurrent IS (12.11% versus 8.15%) (adjusted hazard ratio (HR): 1.352; 95% confidence interval (CI): 1.028–1.78, p = 0.031). Other risk factors included hyperlipidemia (adjusted HR: 1.338; 95% CI: 1.022–1.751, p = 0.034), coronary artery disease (adjusted HR: 1.487; 95% CI: 1.128–1.961, p = 0.005), chronic obstructive pulmonary disease (adjusted HR: 1.499; 95% CI: 1.075–2.091, p = 0.017), and chronic kidney disease (adjusted HR: 1.523; 95% CI: 1.033–2.244, p = 0.033). (4) Conclusion: Patients with BPH who had these risk factors had an increased risk of one-year recurrent IS. The modification of risk factors may prevent recurrent IS.
Suggested Citation
Chun-Gu Cheng & Hsin Chu & Jiunn-Tay Lee & Wu-Chien Chien & Chun-An Cheng, 2020.
"Increased One-Year Recurrent Ischemic Stroke after First-Ever Ischemic Stroke in Males with Benign Prostatic Hyperplasia,"
IJERPH, MDPI, vol. 17(15), pages 1-10, July.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:15:p:5360-:d:389680
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Chien-Lung Chan & Chi-Chang Chang, 2020.
"Big Data, Decision Models, and Public Health,"
IJERPH, MDPI, vol. 17(18), pages 1-7, September.
- Chien-Lung Chan & Chi-Chang Chang, 2022.
"Big Data, Decision Models, and Public Health,"
IJERPH, MDPI, vol. 19(14), pages 1-9, July.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:15:p:5360-:d:389680. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.